Monitoring CAR T cells in peripheral blood by flow cytometry following Tisagenlecleucel in Fundeni Clinical Institute, Bucharest

Introduction: Over the past few years, the introduction of chimeric antigen receptor (CAR) T-cell therapy by the FDA has shown remarkable success in treating various hematologic malignancies. However, the limited response and resistance observed in some patients have hindered its broader application...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Popa Delia C., Sandu Horia M., Suciu Raluca, Ţica Valeria G., Şerbănică Andreea, Şerbănică Ionut, Jercan Cristina, Coriu Daniel, Tanase Alina, Coliţă Anca
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Sciendo 2023-07-01
Edice:	Romanian Journal of Laboratory Medicine
Témata:	car t tisagenlecleucel cellular therapy flow cytometry
On-line přístup:	https://doi.org/10.2478/rrlm-2023-0019
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!